The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


HUMULIN I (ISOPHANE)

100 IU/ML Suspension for Injection

Eli Lilly Nederland B.V.PA2276/002/001

Main Information

Trade NameHUMULIN I (ISOPHANE)
Active SubstancesINSULIN HUMAN
Strength100 IU/ML
Dosage FormSuspension for Injection
Licence HolderEli Lilly Nederland B.V.
Licence NumberPA2276/002/001

Group Information

ATC CodeA10AC01 insulin (human)

Status

Authorised/WithdrawnAuthorised
Licence Issued22/06/1983
Legal status
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot Marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back